Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shree Ganesh Remedies Ltd informed the stock exchanges that director Mr. Gunjan Chandulal Kothia has resigned from the board with immediate effect from September 15, 2025. The change is not due to any governance or personal issues — he is transitioning internally to a new executive role as Head of Business Development and Innovation, designated as Senior Management Personnel of the company. Mr. Kothia, aged 33, holds a degree in Chemical Engineering and a Master's from Leeds University, UK, with about 8 years of R&D experience and 7 years in business development of pharmaceutical intermediates and organic pigments. The board meeting lasted from 5:30 p.m. to 6:30 p.m. on September 15, 2025, and approved both the resignation and the new appointment.
This is a neutral, internal restructuring with no negative governance implications — the person is staying with the company in a different, more operationally focused role. Shareholders are unlikely to see any material impact on the stock price from this announcement.